🇺🇸 FDA
Patent

US 11891626

Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue

granted A61KA61K35/32A61P

Quick answer

US patent 11891626 (Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue) held by DiscGenics, Inc. expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DiscGenics, Inc.
Grant date
Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K35/32, A61P, A61P19/08, A61P43/00